Venlafaxine hydrochloride sustained release capsule and preparation method thereof
A technology of venlafaxine hydrochloride and sustained-release capsules, which can be applied to medical formulas, medical preparations containing no active ingredients, medical preparations containing active ingredients, etc., and can solve the problems of expensive sustained-release materials and high production costs of medicines , to achieve the effect of stable material, easy control, low flammability and good film formation
Active Publication Date: 2012-11-14
LEPU HENGJIUYUAN PHARMA CO LTD
View PDF5 Cites 7 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Patent 200910162006.8, patent name: Venlafaxine Hydrochloride Sustained-release Pellet Capsules Sustained-release coating film adopts polyacrylic acid resin, the sustained-release material is expensive, and the cost of drug production is high
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0018] A venlafaxine sustained-release capsule, the content of the sustained-release capsule is sustained-release pellets, the sustained-release pellets from inside to outside are pellet core, isolation layer, sustained-release layer, pellet core, isolation layer, Sustained-release layer prescriptions are shown in Table 1-1, Table 1-2, and Table 1-3.
[0019]
[0020]
[0021]
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More
Abstract
The invention belongs to the field of pharmaceutical preparations, and discloses a venlafaxine hydrochloride sustained release capsule and a preparation method thereof. The content of the sustained release capsule is a sustained release micro pill, wherein the sustained release pill is successively provided with a pill core, an isolating layer and a sustained release layer from the interior to the exterior, the pill core is prepared from the following constituents according to weight percentage composition: 45-48% of venlafaxine hydrochloride, 15-18% of bulking agent, 3-3.5% of disintegrating agent, 4-6% of povidone K 30, 24-26% of absolute ethyl alcohol and the balance being water; the isolating layer is prepared from the following constituents according to weight percentage composition: 11-13% povidone K30, 83-86% of absolute ethyl alcohol and the balance being talcum powder; the sustained release layer is prepared from the following constituents according to weight percentage composition: 38-42% of ethocel suspension, 0.1-1.0% of polyethylene glycol-60000 and the balance being water, wherein the ethocel accounts for 20-30% of the ethocel suspension in mass; and the preparation method provided by the invention has the following steps of preparing the pill core, packing the isolating layer, packing the sustained release layer and filling a capsule, thus obtaining the sustained release capsule. The venlafaxine hydrochloride sustained release capsule provided by the invention adopts the ethocel, the flammability is low, the hygroscopicity is small, good film formation property can be achieved, the material is stable and is easy to control, and the venlafaxine hydrochloride sustained release capsule is safe and environment-friendly.
Description
technical field [0001] The invention belongs to the technical field of pharmaceutical preparations, in particular to a venlafaxine hydrochloride sustained-release capsule and a preparation method thereof. Background technique [0002] Venlafaxine hydrochloride is an effective anxiolytic and antidepressant. It exists in the form of hydrochloride in the medicament. Its chemical name is: (±)-1-[2-(dimethylamino)-1- (4-Methoxyphenyl) ethyl] cyclohexanol hydrochloride, the chemical structural formula is as follows: [0003] . [0004] Venlafaxine is an ethylamine derivative and is a dual inhibitor of norepinephrine and serotonin reuptake. It has been used in the first-line treatment of depression, mainly for various types of depression, including depression accompanied by anxiety. and generalized anxiety disorder. [0005] U.S. Wyeth Corporation patent application number: 97109594.9, patent name: sustained-release preparation, wherein organic solvents such as dichloromethan...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/52A61K31/137A61K47/38A61P25/22A61P25/24
Inventor 张克军王庆鹏马可鸿梁猛孙冬梅
Owner LEPU HENGJIUYUAN PHARMA CO LTD
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com